APA (7th ed.) Citation

Giallongo, C., Tibullo, D., Parrinello, N. L., La Cava, P., Camiolo, G., Caporarello, N., . . . Di Raimondo, F. (2016). Mesenchymal Stem Cells (MSC) from Patients with Multiple Myeloma Promote Myeloid Cells to Become Granulocytic-Myeloid-Derived Suppressor Cells (G-MDSC) with Immunosuppressive, Bone Resorption and Pro-Angiogenic Activity. Blood, 128(22), 4458. https://doi.org/10.1182/blood.V128.22.4458.4458

Chicago Style (17th ed.) Citation

Giallongo, Cesarina, et al. "Mesenchymal Stem Cells (MSC) from Patients with Multiple Myeloma Promote Myeloid Cells to Become Granulocytic-Myeloid-Derived Suppressor Cells (G-MDSC) with Immunosuppressive, Bone Resorption and Pro-Angiogenic Activity." Blood 128, no. 22 (2016): 4458. https://doi.org/10.1182/blood.V128.22.4458.4458.

MLA (9th ed.) Citation

Giallongo, Cesarina, et al. "Mesenchymal Stem Cells (MSC) from Patients with Multiple Myeloma Promote Myeloid Cells to Become Granulocytic-Myeloid-Derived Suppressor Cells (G-MDSC) with Immunosuppressive, Bone Resorption and Pro-Angiogenic Activity." Blood, vol. 128, no. 22, 2016, p. 4458, https://doi.org/10.1182/blood.V128.22.4458.4458.